ReWalker Sets Guinness World Record for Climbing a London Skyscraper While Wearing an Exoskeleton
Simon Kindleysides is first paralyzed man to climb a 51-story skyscraper; earns his second Guinness World Record using his ReWalk...
Year: 2022
Mata Mata Turtle with Squamous Cell Carcinoma Successfully Treated with Sensus Healthcare’s SRT System by Colorado State University Veterinarian
Joins multiple companion animals and a horse successfully treated with SRTBOCA RATON, Fla. , March 24, 2022 (GLOBE NEWSWIRE) --...
HCW Biologics to Present at 2022 Virtual Growth Conference Sponsored by the Maxim Group and M-Vest
Founder and CEO, Hing C. Wong, Ph.D., to be guest at “Fireside Chat”MIRAMAR, Fla., March 24, 2022 (GLOBE NEWSWIRE) --...
Daré Bioscience to Host Full-year 2021 Financial Results and Company Update Conference Call and Webcast on March 31, 2022
SAN DIEGO, March 24, 2022 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced...
Revolo Biotherapeutics to Participate at SVB Leerink Biopharma Private Company Connect
NEW ORLEANS and LONDON, March 24, 2022 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics (“Revolo Bio” or the “Company”), a company developing...
Monopar Therapeutics Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Program Developments
Validive® Phase 2b/3 VOICE Trial Continues Adding Sites in the U.S. and Europe Camsirubicin Phase 1b Dose-Esclation Trial Clears 2nd...
Immutep Announces Publication of TACTI-002 Abstract at ESMO’s European Lung Cancer Congress 2022
New interim data from TACTI-002 (Part B) evaluating the combination of efti and pembrolizumab in 2nd line, confirmed PD-1/PD-L1 refractory,...
Protara Therapeutics Doses First Patient in ADVANCED-1 Phase 1 Study of TARA-002 in Non-Muscle Invasive Bladder Cancer
NEW YORK, March 24, 2022 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the...
VistaGen to Participate in Fireside Chat at Maxim Group 2022 Virtual Growth Conference
SOUTH SAN FRANCISCO, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc. (Nasdaq: VTGN) (VistaGen), a late clinical-stage, neuro-focused...
Piezo Motion’s Precise Motor Technology Is Now Available in Germany
Piezo Motion partnership with MEV Elektronik will deliver motion control and automation solutions to original equipment manufacturers in central and...
OrthoPediatrics Corp. Launches PediFlex™ Advanced Interlock Clamp System
WARSAW, Ind., March 24, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively...
Sientra Receives Regulatory Approval to Market Breast Implants in Canada
Health Canada approval continues Sientra’s international expansion and growth accelerationSANTA BARBARA, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc....
Longeveron Presents at Second Euro-Geroscience Conference
Longeveron management presents live at the Second Euro-Geroscience Conference and at a pre-meeting task forceMIAMI, March 24, 2022 (GLOBE NEWSWIRE)...
Impel NeuroPharma Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Trudhesa™ Exceeds Fourth Quarter 2021 Prescription Guidance; Strong Launch Continues Into 2022 Demonstrated by 157% Growth Since December 31, 2021...
BioCardia to Host 2021 Financial Results and Corporate Update Conference Call on March 29, 2022
SUNNYVALE, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- BioCardia®, Inc. , a developer of cellular and cell-derived therapeutics for the...
Surrozen Reports Fourth Quarter and Full Year 2021 Financial Results
On Track to Initiate Phase 1 Clinical Trials in Healthy Volunteers for SZN-1326 and SZN-043 in the Third Quarter of...
Ocuphire Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2021 and Provides Corporate Update
Building Momentum with Completion of Patient Enrollment in 4 Late-Stage Trials Multiple Late-Stage Clinical Trial Data Catalysts in 2022:– Nyxol®...
ContraFect Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Provides Business Update
Phase 3 DISRUPT study enrollment continues on course towards conducting interim futility analysis as anticipated in H1 2022YONKERS, N.Y., March...
Gain Therapeutics, Inc. Reports Full Year 2021 Financial Results and Business Update
$36.88 Million in cash as of December 31, 2021, provides runway into second half of 2023 and a strong cash...
KemPharm to Participate in Maxim’s 2022 Virtual Growth Conference
CELEBRATION, Fla., March 24, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery and...
